Sesiuni Satelit - Magnum B

5 Octombrie


11:30 – 12:30 > BRCA mutation specific biomarker for targeted therapy in ovarian cancer

  • Moderator Conf Dr Dana Lucia Stanculeanu
  • Speaker: Prof Dr Tudor Ciuleanu, Dr Dragos Median
12:30 – 13:00 > Contemporary Treatment Strategies in aRCC .Considerations for Patient Management
  • Speaker : Prof. Cezary Szczylik (Poland) Prof. Ciuleanu Tudor Eliade
13:00 – 13:30 > Actual challenges in individualizing the treatment for mCRPC patients
  • Lector: conf. dr. Gabriel Kacso
13:30 – 14:30 > Lunch 15:30 – 16:30 > A new standard in the treatment of advanced gastric cancer?
  • Speakers: Prof dr Tudor Ciuleanu, Conf Dr Laura Mazilu, Dr. Filip Dumitru
16:30 – 17:00 > Centrul Oncologic Sanador. Excelenta in oncologie medicala, radioterapie si medicina nucleara
  • Speaker : Dr. Mircea Dediu
17:00 - 17:30 > Coffe break 17:30 – 18:30 > The Art of Innovation makes all the difference
  • Moderator: Doctor Mircea Dediu
  • Speakeri: Doctor Daniela Grecea, Doctor Larisa Ciule, Doctor Mihai Marinca




6 OCTOMBRIE


11:00 – 11:30 - Soft tissue sarcoma - a real chanllenge!

  • Speakers: Dr. Razvan Ovidiu Curca, Conf. Dr. Lucian Stanculeanu
11:30 – 12:00 New therapeutic paradigm in advanced NSCLC and RCC treatment
  • Speakers: Prof. Dr. Tudor Ciuleanu
12:30 – 13:00 - The potential of CDK4/6 inhibition
  • Speaker : Conf. Dr. Dana Stanculeanu
13:00 – 14:00 – Lunch 14:00 – 14:30 - From Clinical Trials to Clinical Practice. Implementing new paradigms in stage III NSCLC.
  • Speaker : Dr Razvan Curca si Dr Laura Mazilu
14:30 – 15:00 - Role of Vectibix in achieving early tumor shrinkage in mCRC
  • Speaker : Dediu Mircea, MD
15:00 – 15:30 - Pembrolizumab as first line option in NSCLC with high PD-L1 expression
  • Speaker : Dr. Mircea Dediu
15:30 – 16:00 – Coffee break 16:00 – 16:30 - Redefining therapeutic algorithm in metastatic melanoma
  • Speaker : Dr. Larisa Ciule
16:30 – 17:00 - An extra chance for patients with prostate cancer resistant to metastatic castration: Jevtana (Cabazitaxel)
  • Speaker : Prof. Dr. Tudor Ciuleanu
17:00 – 17:30 - TALKS on mCRC clinical practice
  • Speaker : Dr Razvan Curca, Conf Dr Serban Negru
17:30 – 18:00 - Atezolizumab NSCLC Use of Immunotherapy in NSCLC: Success& Challenges in clinical practice Atezolizumab mUC Immunotherapy: advances in mUC management
  • Speaker : Dr Mircea Dediu , Conf dr Laura Mazilu





Program congres - Magnum A

5 Octombrie


11:30 – 12:30 > BRCA mutation specific biomarker for targeted therapy in ovarian cancer

  • Moderator Conf Dr Dana Lucia Stanculeanu
  • Speaker: Prof Dr Tudor Ciuleanu, Dr Dragos Median
12:30 – 13:00 > Contemporary Treatment Strategies in aRCC .Considerations for Patient Management
  • Speaker : Prof. Cezary Szczylik (Poland) Prof. Ciuleanu Tudor Eliade
13:00 – 13:30 > Actual challenges in individualizing the treatment for mCRPC patients
  • Lector: conf. dr. Gabriel Kacso
13:30 – 14:30 > Lunch 15:30 – 16:30 > A new standard in the treatment of advanced gastric cancer?
  • Speakers: Prof dr Tudor Ciuleanu, Conf Dr Laura Mazilu, Dr. Filip Dumitru
16:30 – 17:00 > Centrul Oncologic Sanador. Excelenta in oncologie medicala, radioterapie si medicina nucleara
  • Speaker : Dr. Mircea Dediu
17:00 - 17:30 > Coffe break 17:30 – 18:30 > The Art of Innovation makes all the difference
  • Moderator: Doctor Mircea Dediu
  • Speakeri: Doctor Daniela Grecea, Doctor Larisa Ciule, Doctor Mihai Marinca




6 OCTOMBRIE


11:00 – 11:30 - Soft tissue sarcoma - a real chanllenge!

  • Speakers: Dr. Razvan Ovidiu Curca, Conf. Dr. Lucian Stanculeanu
11:30 – 12:00 New therapeutic paradigm in advanced NSCLC and RCC treatment
  • Speakers: Prof. Dr. Tudor Ciuleanu
12:30 – 13:00 - The potential of CDK4/6 inhibition
  • Speaker : Conf. Dr. Dana Stanculeanu
13:00 – 14:00 – Lunch 14:00 – 14:30 - From Clinical Trials to Clinical Practice. Implementing new paradigms in stage III NSCLC.
  • Speaker : Dr Razvan Curca si Dr Laura Mazilu
14:30 – 15:00 - Role of Vectibix in achieving early tumor shrinkage in mCRC
  • Speaker : Dediu Mircea, MD
15:00 – 15:30 - Pembrolizumab as first line option in NSCLC with high PD-L1 expression
  • Speaker : Dr. Mircea Dediu
15:30 – 16:00 – Coffee break 16:00 – 16:30 - Redefining therapeutic algorithm in metastatic melanoma
  • Speaker : Dr. Larisa Ciule
16:30 – 17:00 - An extra chance for patients with prostate cancer resistant to metastatic castration: Jevtana (Cabazitaxel)
  • Speaker : Prof. Dr. Tudor Ciuleanu
17:00 – 17:30 - TALKS on mCRC clinical practice
  • Speaker : Dr Razvan Curca, Conf Dr Serban Negru
17:30 – 18:00 - Atezolizumab NSCLC Use of Immunotherapy in NSCLC: Success& Challenges in clinical practice Atezolizumab mUC Immunotherapy: advances in mUC management
  • Speaker : Dr Mircea Dediu , Conf dr Laura Mazilu





PROGRAM ASISTENȚI MEDICALI

 05.10.2018

PROGRAM – 05.10.2018

14:30 – 17:00 – Sustinere lucrari


  • Transformari fundamentale in metabolismul cancerului
Autor : Dr. Maria Iuliana Gruia Analiza proteomică a markerilor moleculari plasmatici ca predictori ai cancerului tiroidian diferențiat Autor : Dr. Ancuţa Elena BACIU
  • Brahiterapia cu rată ridicată de doza (BT-HDR) în iradierea sarcomului Kapoși (SK)
Autor : Mădălina CROITORIU, Dr. Ancuța Elena BACIU, Drd. Lucia Elena ENCIU, Dr. Gabriel BARANGĂ, Laurențiu BUSUIOC, Miu Cosmin, Conf. Dr. Xenia Elena BACINSCHI
  • Efectele biologice induse de 68Ga - conjugat cu peptide asupra celulelor tumorale experimentale
Autor : Marieta Elena Panait, Antonela Busca, Valentiuna Negoita, Mirela Dumitru, Maria Iuliana Gruia
  • BIOLOGICAL EFFECTS OF RUTHENIUM (III) COMPOUNDS ASSOCIATED TO CYCLODEXTRINS IN HUMAN COLORECTAL CANCER
Autor : Mirela Mihaila, Camelia Hotnog, Viviana Roman, Marinela Bostan, Valentina Uivarosi, Lorelei I. Brasoveanu
  • TREATMENT MODULATION OF BIOMARKERS ASSOCIATED TO COLON CANCER CELL LINES WITH DIFFERENT P53 MUTATIONAL STATUS
Autor: Camelia Mia Hotnog, Mirela Mihaila, Marinela Bostan, Lorelei Irina Brasoveanu




17:00 – 17:30 – Coffee break


– Coffee break




17:30 – 19:00 – Sustinere lucrari


  • The expression pattern of HOXA11 AS in cervical cancer precursor lesions
Autor : Iulia V. Iancu, Adrian Albulescu, Alina Fudulu, Adriana Plesa, Irina Huica, Demetra Socolov, Gabriela Anton, Anca Botezatu
  • Rarity of rare tumors
Autor : Bondei Irina-Mihaela, Todor Nicolae, Nagy Viorica
  • Molecular and cellular heterogeneity in glioblastoma: Which are the implications of patient’s care and treatment selection?
Autor: Ionela Bîzu
  • Volumetric Modulated Arc Therapy for Total Marrow Irradiation TMI Experience of Bucharest Amethyst Clinic
Autor : Violeta Ciocâltei, Răducu Popa, Daniela Adam, Nicoleta Guraliuc, Florin Ciubotaru
  • Experimental validation of CT density table for dose calculation in radiation treatment planning system
Autor : Schultes Noemi, Dordai Dan, Eva Andrea, Farcasanu Alexandru, Domokos Reka
  • Butterfly technique for Intensity-modulated radiation therapy (IMRT) and Volumetric-modulated arc therapy (VMAT) in Hodgkin’s lymphoma: A dosimetric comparison
Autor: Farcasanu Alexandru Stefan; Schultes Noemi; Eva Andrea; Dordai Dan; Zahu Renata; Kacso Gabriel





PROGRAM FIZICIENI

PROGRAM FIZICIENI - 5.10.2018

14:30 – 17:00 – Sustinere lucrari


  • Transformari fundamentale in metabolismul cancerului
Autor : Dr. Maria Iuliana Gruia Analiza proteomică a markerilor moleculari plasmatici ca predictori ai cancerului tiroidian diferențiat Autor : Dr. Ancuţa Elena BACIU
  • Brahiterapia cu rată ridicată de doza (BT-HDR) în iradierea sarcomului Kapoși (SK)
Autor : Mădălina CROITORIU, Dr. Ancuța Elena BACIU, Drd. Lucia Elena ENCIU, Dr. Gabriel BARANGĂ, Laurențiu BUSUIOC, Miu Cosmin, Conf. Dr. Xenia Elena BACINSCHI
  • Efectele biologice induse de 68Ga - conjugat cu peptide asupra celulelor tumorale experimentale
Autor : Marieta Elena Panait, Antonela Busca, Valentiuna Negoita, Mirela Dumitru, Maria Iuliana Gruia
  • BIOLOGICAL EFFECTS OF RUTHENIUM (III) COMPOUNDS ASSOCIATED TO CYCLODEXTRINS IN HUMAN COLORECTAL CANCER
Autor : Mirela Mihaila, Camelia Hotnog, Viviana Roman, Marinela Bostan, Valentina Uivarosi, Lorelei I. Brasoveanu
  • TREATMENT MODULATION OF BIOMARKERS ASSOCIATED TO COLON CANCER CELL LINES WITH DIFFERENT P53 MUTATIONAL STATUS
Autor: Camelia Mia Hotnog, Mirela Mihaila, Marinela Bostan, Lorelei Irina Brasoveanu




17:00 – 17:30 – Coffee break


– Coffee break




17:30 – 19:00 – Sustinere lucrari


  • The expression pattern of HOXA11 AS in cervical cancer precursor lesions
Autor : Iulia V. Iancu, Adrian Albulescu, Alina Fudulu, Adriana Plesa, Irina Huica, Demetra Socolov, Gabriela Anton, Anca Botezatu
  • Rarity of rare tumors
Autor : Bondei Irina-Mihaela, Todor Nicolae, Nagy Viorica
  • Molecular and cellular heterogeneity in glioblastoma: Which are the implications of patient’s care and treatment selection?
Autor: Ionela Bîzu
  • Volumetric Modulated Arc Therapy for Total Marrow Irradiation TMI Experience of Bucharest Amethyst Clinic
Autor : Violeta Ciocâltei, Răducu Popa, Daniela Adam, Nicoleta Guraliuc, Florin Ciubotaru
  • Experimental validation of CT density table for dose calculation in radiation treatment planning system
Autor : Schultes Noemi, Dordai Dan, Eva Andrea, Farcasanu Alexandru, Domokos Reka
  • Butterfly technique for Intensity-modulated radiation therapy (IMRT) and Volumetric-modulated arc therapy (VMAT) in Hodgkin’s lymphoma: A dosimetric comparison
Autor: Farcasanu Alexandru Stefan; Schultes Noemi; Eva Andrea; Dordai Dan; Zahu Renata; Kacso Gabriel





SPATIILE DE CAZARE AU FOST EPUIZATE - INREGISTRARILE PROCESATE INCEPAND CU 18.09.2018 ORA 18:00 NU VOR MAI CONTINE CAZARE! 

SECRETARIAT ȘTIINȚIFIC

 

Societatea Romana de Radioterapie 

Strada Fundeni, nr. 252, sector 1, Bucuresti​

OPERATOR CONGRES

 

SC Business Travel Turism SRL
Adresă: Aleea Alexandru 9A, sector 1, Bucureşti
Tel: 021/231.56.15; Fax: 021/312.67.08
Email: congresoncologie@businesstravel.ro